Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
Authors
Keywords
-
Journal
Science Translational Medicine
Volume -, Issue -, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-02-15
DOI
10.1126/scitranslmed.abn8057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
- (2022) Henning Gruell et al. NATURE MEDICINE
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
- (2021) Nicole L. Washington et al. CELL
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
- (2021) Gabriele Anichini et al. NEW ENGLAND JOURNAL OF MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
- (2021) Finlay Campbell et al. Eurosurveillance
- Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
- (2021) Dami A. Collier et al. NATURE
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 variants of concern are emerging in India
- (2021) Jasdeep Singh et al. NATURE MEDICINE
- Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
- (2021) Heather M. Scobie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis
- (2021) Alessia Bignucolo et al. Vaccines
- Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers
- (2021) Niki Vassilaki et al. Microorganisms
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
- (2021) Cong Zeng et al. mBio
- Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
- (2021) Barak Mizrahi et al. Nature Communications
- Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
- (2021) Cong Zeng et al. Cell and Bioscience
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors
- (2020) Cong Zeng et al. JCI Insight
- IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
- (2015) Jingyou Yu et al. Cell Reports
- Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors
- (2010) Dmitriy Mazurov et al. PLoS Pathogens
- Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferase
- (2008) Aaron R. Goerke et al. METABOLIC ENGINEERING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started